Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ventures VII L. P. Avalon currently holds 7,670,442 shares of AKESIS PHARMACEUTICALS, INC. (AKES.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures VII L. P. Avalon has been a net buyer of AKES.OB stock. They have purchased $2.2M and sold $0 worth of shares.
Ventures VII L. P. Avalon's most recent insider trade was on Mar 25, 2008, when they purchased 2,352,942 shares at $0.85 per share.
Ventures VII L. P. Avalon serves as Executive at AKESIS PHARMACEUTICALS, INC. (AKES.OB). They have executed 47 insider transactions totaling $2.2M over their tenure at the company.
Ventures VII L. P. Avalon holds the position of Executive at AKESIS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Ventures VII L. P. Avalon has shown a buying trading pattern, with $2.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ventures VII L. P. Avalon was on Mar 25, 2008, when they purchased $2.0M worth of AKES.OB shares. This transaction involved 2,352,942 shares at $0.85 per share.
Ventures VII L. P. Avalon currently owns 7,670,442 shares of AKESIS PHARMACEUTICALS, INC. (AKES.OB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ventures VII L. P. Avalon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ventures VII L. P. Avalon has 47 Form 4 filings on record as an insider at AKESIS PHARMACEUTICALS, INC..
Set alerts for Ventures VII L. P. Avalon and 40,000+ other insiders.